This inventor holds 1 USPTO granted patent. Top assignees: Kali-Chemie Aktiengesellschaft, Pfrimmer Kabi Gmbh & Co. Kg. Active years: 1992.
Company Filing History:
1 out of 102 
1 out of 1 Years Active: 1992
Title: Klaus Gerling: Innovator in Pharmaceuticals and Dietetics
Introduction
Klaus Gerling is a notable inventor based in Laatzen, Germany. He has made significant contributions to the field of pharmaceuticals and dietetics, particularly through his innovative work on acylamino acid derivatives. His research has implications for improving nitrogen metabolism in large mammals, which is crucial for treating various health conditions.
Latest Patents
Klaus Gerling holds a patent for "Pharmaceuticals and dietetics containing acylamino acid derivatives." This patent describes acylamino carboxylic acid derivatives that possess valuable pharmacological properties. These compounds are particularly effective in favorably influencing nitrogen metabolism, making them useful as active ingredients in pharmaceutical and dietetic compositions aimed at treating or preventing nitrogen metabolism disturbances caused by liver or kidney damage. He has 1 patent to his name.
Career Highlights
Throughout his career, Klaus Gerling has worked with prominent companies in the pharmaceutical industry. Notable among these are Kali-Chemie Aktiengesellschaft and Pfrimmer Kabi GmbH & Co. KG. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.
Collaborations
Klaus Gerling has collaborated with several professionals in his field, including Andreas Meier and Klaus Langer. These collaborations have likely enriched his research and development efforts, leading to advancements in pharmaceutical applications.
Conclusion
Klaus Gerling's contributions to pharmaceuticals and dietetics highlight his role as an innovator in the industry. His patent on acylamino acid derivatives showcases his commitment to improving health outcomes through scientific research.